These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23205864

  • 1. Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth.
    El-Gharib MN, El-Hawary TM.
    J Matern Fetal Neonatal Med; 2013 May; 26(7):716-9. PubMed ID: 23205864
    [Abstract] [Full Text] [Related]

  • 2. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S, Bagga R, Bansal P, Kalra J, Kumar P.
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone.
    Maher MA, Abdelaziz A, Ellaithy M, Bazeed MF.
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):215-22. PubMed ID: 23016508
    [Abstract] [Full Text] [Related]

  • 5. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G, Khalifeh A, Elimian A, Bahrami E, Chaman-Ara K, Bahrami MA, Berghella V.
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [Abstract] [Full Text] [Related]

  • 6. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N, Timmesfeld N, Kyvernitakis I, Goerges J, Arabin B.
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [Abstract] [Full Text] [Related]

  • 7. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R, Nicolaides KH, Conde-Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS.
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
    Elimian A, Smith K, Williams M, Knudtson E, Goodman JR, Escobedo MB.
    Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M, Shi C, Zhang X, Fan L.
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix.
    Hezelgrave NL, Watson HA, Ridout A, Diab F, Seed PT, Chin-Smith E, Tribe RM, Shennan AH.
    BMC Pregnancy Childbirth; 2016 Nov 21; 16(1):358. PubMed ID: 27871275
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progesterone and preterm birth.
    Norman JE.
    Int J Gynaecol Obstet; 2020 Jul 21; 150(1):24-30. PubMed ID: 32524598
    [Abstract] [Full Text] [Related]

  • 14. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, Molina FS, Savvidou M, De La Calle M, Persico N, Quezada Rojas MS, Sau A, Greco E, O'Gorman N, Plasencia W, Pereira S, Jani JC, Valino N, Del Mar Gil M, Maclagan K, Wright A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2021 Jan 21; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [Abstract] [Full Text] [Related]

  • 15. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ, Nguyen LK, Pham TD, He YTN, Vu KN, Phan MTN, Le TQ, Le CH, Vuong LN, Mol BW.
    Obstet Gynecol; 2019 Mar 21; 133(3):459-467. PubMed ID: 30741812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
    Boelig RC, Locci M, Saccone G, Gragnano E, Berghella V.
    Am J Obstet Gynecol MFM; 2022 Sep 21; 4(5):100658. PubMed ID: 35562009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The association of different progesterone preparations with preterm birth prevention.
    Krispin E, Hadar E, Chen R, Wiznitzer A, Kaplan B.
    J Matern Fetal Neonatal Med; 2019 Oct 21; 32(20):3452-3457. PubMed ID: 29699436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.